HUP0500645A2 - Terc-Butil-taxán-származékok enzimes rezolválása - Google Patents
Terc-Butil-taxán-származékok enzimes rezolválásaInfo
- Publication number
- HUP0500645A2 HUP0500645A2 HU0500645A HUP0500645A HUP0500645A2 HU P0500645 A2 HUP0500645 A2 HU P0500645A2 HU 0500645 A HU0500645 A HU 0500645A HU P0500645 A HUP0500645 A HU P0500645A HU P0500645 A2 HUP0500645 A2 HU P0500645A2
- Authority
- HU
- Hungary
- Prior art keywords
- butyl
- enzymatic resolution
- taxane derivatives
- mixture
- carboxyl ester
- Prior art date
Links
- -1 t-butyl taxane derivatives Chemical class 0.000 title abstract 3
- 230000002255 enzymatic effect Effects 0.000 title 1
- 239000000203 mixture Substances 0.000 abstract 3
- 102000004157 Hydrolases Human genes 0.000 abstract 2
- 108090000604 Hydrolases Proteins 0.000 abstract 2
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 239000002246 antineoplastic agent Substances 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 1
- 230000007062 hydrolysis Effects 0.000 abstract 1
- 238000006460 hydrolysis reaction Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 244000005700 microbiome Species 0.000 abstract 1
- 230000000707 stereoselective effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
- C12P17/10—Nitrogen as only ring hetero atom
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
- C12P17/02—Oxygen as only ring hetero atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
- C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
- C07D205/06—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D205/08—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D305/00—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
- C07D305/14—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P41/00—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture
- C12P41/003—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture by ester formation, lactone formation or the inverse reactions
- C12P41/004—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture by ester formation, lactone formation or the inverse reactions by esterification of alcohol- or thiol groups in the enantiomers or the inverse reaction
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Health & Medical Sciences (AREA)
- General Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Analytical Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Epoxy Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
A találmány tárgya eljárás az általános képletű vegyület - amelyképletében R1 jelentése -O-C(O)alkil-, -O-C(O)aril- vagy -O-C(O)cikloalkil-csoport - cisz- és transz-enantiomereit tartalmazóelegy rezolválására, amely szerint az enantiomerelegyet az említettelegy sztereoszelektív hidrolízisét katalizáló karboxil-észter-hidroláz enzimmel vagy mikroorganizmusból származó karboxil-észter-hidroláz enzimmel hozzák érintkezésbe. A találmány értelmében az ígykapott enantiomereket olyan daganatellenes szerek előállításáraalkalmazzák, amelyek különösen alkalmasak orális adagolásra.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US31375701P | 2001-08-21 | 2001-08-21 | |
PCT/US2002/026810 WO2003016543A2 (en) | 2001-08-21 | 2002-08-21 | Enzymatic resolution of t-butyl taxane derivatives |
Publications (2)
Publication Number | Publication Date |
---|---|
HUP0500645A2 true HUP0500645A2 (hu) | 2005-09-28 |
HUP0500645A3 HUP0500645A3 (en) | 2009-03-02 |
Family
ID=23217015
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU0500645A HUP0500645A3 (en) | 2001-08-21 | 2002-08-21 | Enzymatic resolution of t-butyl taxane derivatives |
Country Status (13)
Country | Link |
---|---|
US (1) | US7063977B2 (hu) |
EP (1) | EP1425407A4 (hu) |
JP (1) | JP2007503201A (hu) |
KR (1) | KR20040053114A (hu) |
CN (1) | CN1294274C (hu) |
AU (1) | AU2002323346B2 (hu) |
BR (1) | BR0211999A (hu) |
CZ (1) | CZ2004254A3 (hu) |
HU (1) | HUP0500645A3 (hu) |
IL (1) | IL160061A0 (hu) |
MX (1) | MXPA04001631A (hu) |
PL (1) | PL374278A1 (hu) |
WO (1) | WO2003016543A2 (hu) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108084126A (zh) * | 2016-11-21 | 2018-05-29 | 山东国际生物科技园发展有限公司 | 化合物FuramycinsⅠ和Ⅱ及其制备方法和应用 |
Family Cites Families (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MY110249A (en) | 1989-05-31 | 1998-03-31 | Univ Florida State | Method for preparation of taxol using beta lactam |
US5175315A (en) | 1989-05-31 | 1992-12-29 | Florida State University | Method for preparation of taxol using β-lactam |
US5274124A (en) | 1991-09-23 | 1993-12-28 | Florida State University | Metal alkoxides |
US5284865A (en) | 1991-09-23 | 1994-02-08 | Holton Robert A | Cyclohexyl substituted taxanes and pharmaceutical compositions containing them |
US5243045A (en) | 1991-09-23 | 1993-09-07 | Florida State University | Certain alkoxy substituted taxanes and pharmaceutical compositions containing them |
US5229526A (en) | 1991-09-23 | 1993-07-20 | Florida State University | Metal alkoxides |
US5227400A (en) | 1991-09-23 | 1993-07-13 | Florida State University | Furyl and thienyl substituted taxanes and pharmaceutical compositions containing them |
CA2087359A1 (en) * | 1992-01-15 | 1993-07-16 | Ramesh N. Patel | Enzymatic processes for resolution of enantiomeric mixtures of compoundsuseful as intermediates in the preparation of taxanes |
US5939561A (en) * | 1992-03-10 | 1999-08-17 | Rhone-Poulence Rorer S.A. | Process for the preparation of β-phenylisoserine and β-lactam and their analogues |
US5254580A (en) | 1993-01-19 | 1993-10-19 | Bristol-Myers Squibb Company | 7,8-cyclopropataxanes |
US5294637A (en) | 1992-07-01 | 1994-03-15 | Bristol-Myers Squibb Company | Fluoro taxols |
CA2100808A1 (en) | 1992-10-01 | 1994-04-02 | Vittorio Farina | Deoxy paclitaxels |
US5420337A (en) * | 1992-11-12 | 1995-05-30 | E. R. Squibb & Sons, Inc. | Enzymatic reduction method for the preparation of compounds useful for preparing taxanes |
US5973160A (en) | 1992-12-23 | 1999-10-26 | Poss; Michael A. | Methods for the preparation of novel sidechain-bearing taxanes |
ATE309229T1 (de) | 1992-12-23 | 2005-11-15 | Bristol Myers Squibb Co | Seitenkette tragende taxanen und deren zwischenprodukten |
US5840929A (en) | 1995-04-14 | 1998-11-24 | Bristol-Myers Squibb Company | C4 methoxy ether derivatives of paclitaxel |
TW354293B (en) | 1995-06-06 | 1999-03-11 | Bristol Myers Squibb Co | Prodrugs of paclitaxel derivatives |
DE69832173T2 (de) | 1997-05-27 | 2006-08-03 | IVAX RESEARCH, INC., Miami | Zusammensetzungen zur oralen verabreichung von taxanen und deren verwendung |
US6916942B2 (en) | 2000-02-03 | 2005-07-12 | Bristol-Myers Squibb Company | Process for the preparation of C-4 carbonate taxanes |
US6750246B1 (en) | 2000-02-03 | 2004-06-15 | Bristol-Myers Squibb Company | C-4 carbonate taxanes |
US20050020685A1 (en) * | 2003-06-12 | 2005-01-27 | Skonezny Paul M. | Process for recovery of 6-aminopenicillanic acid from an aqueous discharge stream |
-
2002
- 2002-08-20 US US10/223,800 patent/US7063977B2/en not_active Expired - Fee Related
- 2002-08-21 CN CNB028162935A patent/CN1294274C/zh not_active Expired - Fee Related
- 2002-08-21 HU HU0500645A patent/HUP0500645A3/hu unknown
- 2002-08-21 WO PCT/US2002/026810 patent/WO2003016543A2/en active Application Filing
- 2002-08-21 KR KR10-2004-7002472A patent/KR20040053114A/ko not_active Application Discontinuation
- 2002-08-21 EP EP02757323A patent/EP1425407A4/en not_active Withdrawn
- 2002-08-21 IL IL16006102A patent/IL160061A0/xx unknown
- 2002-08-21 BR BR0211999-4A patent/BR0211999A/pt not_active IP Right Cessation
- 2002-08-21 MX MXPA04001631A patent/MXPA04001631A/es unknown
- 2002-08-21 PL PL02374278A patent/PL374278A1/xx unknown
- 2002-08-21 JP JP2003521850A patent/JP2007503201A/ja not_active Withdrawn
- 2002-08-21 CZ CZ2004254A patent/CZ2004254A3/cs unknown
- 2002-08-21 AU AU2002323346A patent/AU2002323346B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
WO2003016543A3 (en) | 2003-07-24 |
AU2002323346B2 (en) | 2007-09-20 |
JP2007503201A (ja) | 2007-02-22 |
US7063977B2 (en) | 2006-06-20 |
US20030069415A1 (en) | 2003-04-10 |
PL374278A1 (en) | 2005-10-03 |
KR20040053114A (ko) | 2004-06-23 |
CN1545555A (zh) | 2004-11-10 |
WO2003016543A2 (en) | 2003-02-27 |
MXPA04001631A (es) | 2004-07-08 |
HUP0500645A3 (en) | 2009-03-02 |
IL160061A0 (en) | 2004-06-20 |
EP1425407A4 (en) | 2007-02-21 |
CZ2004254A3 (cs) | 2004-10-13 |
EP1425407A2 (en) | 2004-06-09 |
CN1294274C (zh) | 2007-01-10 |
BR0211999A (pt) | 2005-08-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2230790T3 (es) | Procedimientos enzimaticos para la resolucion de mezclas enantiomericas de compuestos utiles como intermedios en la preparacion de taxanos. | |
PT1812581E (pt) | Processo de preparação de β¿lactamas opticamente activas protegidas por n-carbamato através de resolução óptica empregando uma lipase de candida antarctica | |
BR9709099A (pt) | Processos para preparar ácido ascórbico ácido 2-ceto-l.gulônico e um éster de ácido 2-ceto-l-gulônico e mistura contendo ácido ascórbico | |
Arroyo et al. | Biocatalysis for industrial production of active pharmaceutical ingredients (APIs) | |
Elson et al. | The identification of three new biosynthetic intermediates and one further biosynthetic enzyme in the clavulanic acid pathway | |
WO2003061718A3 (en) | Medical articles having enzymatic surfaces for localized therapy | |
HUP0500645A2 (hu) | Terc-Butil-taxán-származékok enzimes rezolválása | |
Kataoka et al. | Microbial enzymes involved in lactone compound metabolism and their biotechnological applications | |
JP2769194B2 (ja) | 酵素分解方法 | |
Okamoto et al. | Drastic enhancement of the enantioselectivity of lipase-catalysed esterification in organic solvents by the addition of metal ions | |
BR9714099A (pt) | Revolução enzimática de ésteres de ácido acético-benzodiazepina com lipase | |
Majewska et al. | Simple and effective method for the deracemization of ethyl 1-hydroxyphosphinate using biocatalysts with lipolytic activity | |
HUP0102348A2 (hu) | Új eljárás szintézis-intermedierek előállítására | |
EP0927755A3 (en) | Haloaccloacetate reductase, method for producing said enzyme, and method for producing alcohols using said enzyme | |
WO2004003001A1 (en) | Process for the enzymatic resolution of 1,3-dioxolane-4-carboxylates | |
WO1992006182A1 (en) | D-pantolactone hydrolase and production thereof | |
EP0997534A3 (de) | Verfahren zur Racematspaltung von Arylalkylcarbonsäureestern | |
CY1105864T1 (el) | Ενζυμικη διαδικασια για την εναντιομepικη διασπαση αμινοξεων | |
ATE445702T1 (de) | Butinol i esterase | |
HUP9801621A2 (hu) | Új eszteráz és eljárás optikailag aktív chromanvegyületek előállítására | |
WO2004081220A3 (en) | A process for enzymatically resolving an enantiomeric mixture of alpha-hydroxy acids | |
JP4765358B2 (ja) | 光学活性なn−保護−プロパルギルグリシンの製造方法 | |
FI935712A0 (fi) | Foerfarande foer enzymatisk framstaellning av optiskt aktiva transglycidsyraestrar | |
JP4633934B2 (ja) | 光学活性な1−アミノ−4−(ヒドロキシルメチル)−シクロペンタ−2−エン誘導体の製造方法 | |
ES2110736T3 (es) | Esterasa y su utilizacion en biotransformacion. |